Summary
Medtronic will shutter its Santa Rosa facility that produces coronary stents and other heart-related products over the next two years as the device maker also looks to restructure its cardio business.
The closure of the facility, which has operated at the site for almost 30 years, is expected to im…
Source: Fierce Biotech
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
